Genmab A/S $574.50 (+19.20, 3.46%)

Buy or Sell Report US

Analysis for Genmab A/S

Summary
LONGBUY: Best moves 25 which gains 2823.43, return on capital invested 5.97%
Details
Systematic Stock Control...Version 3.1.2.18187: x64 MS Windows
Copyright© Graham Armstrong, 1997, 2003, 2021-2026

Report file for: Genmab A/S
Published on: 30 October 2026 20:31:30 -06:00

                                 Raw Data Range

  Hi-Low         First          Last        Lowest       Highest
     252      283.1000      574.5000      232.3400      580.0000

                       Hi-Low Time taken: 00:00.0000048

===============================================================================
                               Maximum Reduction

              Polynomials 2, Moves 7, Sigma 12.0564, Reduction 94

                              Buy or Sell Summary

    Move     Alpha     Sigma    Investment     Return     Mean    Percent    Periods
       1    100.00      0.00             0          0     0.00       0.00          0
       2     66.67    373.25      33082.19     -48.33    -0.44      -0.15        109
       3     50.00    132.38      35361.83    -316.52    -2.75      -0.90        115
       4     40.00     93.30      31918.88     -11.99    -0.11      -0.04        106
       5     33.33     80.25      35261.94    -157.14    -1.35      -0.45        116
       6     28.57     68.61      35243.58    -379.51    -3.27      -1.08        116
       7     25.00     56.37      40203.39      -5.17    -0.04      -0.01        134
       8     22.22     44.85      46082.88     127.69     0.82       0.28        155
       9     20.00     35.02      42526.01    -292.26    -2.04      -0.69        143
      10     18.18     27.13       37331.3    -314.26    -2.55      -0.84        123
      11     16.67     21.02      36950.46    -468.12    -3.84      -1.27        122
      12     15.38     16.36      30956.95     -111.9    -1.09      -0.36        103
      13     14.29     12.84       31081.3    -227.51    -2.19      -0.73        104
      14     13.33     10.17      35634.83    -162.09    -1.36      -0.45        119
      15     12.50      8.13      36402.08    -304.01    -2.51      -0.84        121
      16     11.76      6.56      35241.92    -485.27    -4.18      -1.38        116
      17     11.11      5.34      34534.17    -650.15    -5.70      -1.88        114
      18     10.53      4.38      35313.76     153.36     1.33       0.43        115
      19     10.00      3.62      36528.62      144.9     1.23       0.40        118
      20      9.52      3.01      35318.69    -579.76    -5.09      -1.64        114
      21      9.09      2.51      38348.48     222.23     1.78       0.58        125
      22      8.70      2.11      40512.49     330.81     2.49       0.82        133
      23      8.33      1.79      42578.85    1522.87    10.88       3.58        140
      24      8.00      1.52      38175.34    2379.08    18.59       6.23        128
      25      7.69      1.30      47332.17    2823.43    17.54       5.97        161

  LONGBUY: Best moves 25 which gains 2823.43, return on capital invested 5.97%

 Guidance is to LONGBUY, Last Effect 574.5, minimum underlying current price 10

    Guidance is to LONGBUY, Average Return 17.54%, minimum average return 5%

Guidance is to LONGBUY, Invested Percentage 63.89%, minimum invested periods percentage 30%

                      Overall Time taken: 00:00.0230780


/...End of report

Casting Forward Corporation, trading as Scientific Decisions Consultants
Address: 1322 18 Avenue Northwest, Calgary, Alberta T2M 0W4, Canada
Telephone: +1 (587) 885 3191
Email: shares@scidec.net
Website: https://ssc.castfwd.com/
GNMSF @ US Analysis 89*